NCT06385184 · Gregory Wallace
Social & QoL Behaviors in Parkinson's Disease
What this study is about
Adults with Parkinson's Disease experience an array of challenges and changes in daily living, behaviors, and functioning throughout the progression of their condition. The investigators want to learn more about the effects of Parkinson's Disease on individuals' social behavior and quality of life (QoL) compared to people of the same age without Parkinson's Disease.
View original scientific description
Adults with Parkinson's Disease experience an array of challenges and changes in daily living, behaviors, and functioning throughout the progression of their condition. The investigators want to learn more about the effects of Parkinson's Disease on individuals' social behavior and quality of life (QoL) compared to people of the same age without Parkinson's Disease.
Interventions
OTHER
No Intervention
Observational study with no intervention
Primary outcome measures
Subjective Quality of Life
Time frame: through study completion, an average of 1 year
satisfaction with different aspects of life, such as health and social relationships
Social Behavior
Time frame: through study completion, an average of 1 year
ability to interact with others
Activities of Daily Living
Time frame: through study completion, an average of 1 year
ability to complete tasks to be independent
Mental Health
Time frame: through study completion, an average of 1 year
depression and anxiety symptoms
Cognition
Time frame: through study completion, an average of 1 year
memory and executive function challenges and strengths
Who can participate
This study lists these criteria on ClinicalTrials.gov. A study coordinator reviews eligibility during screening — this page does not determine whether you qualify.
Inclusion criteria
- Have been diagnosed with Parkinsons Disease by a healthcare professional
- Are at least 40 years old
Exclusion criteria
- Possess a diagnosis of autism or any other developmental disability (e.g., Down syndrome) Neurotypical group Inclusion Criteria:
- Are at least 40 years old Exclusion Criteria:
- Have been diagnosed with Parkinson's disease by a healthcare professional
- Possess a diagnosis of autism or any other developmental disability (e.g., Down syndrome)
Where
- Washington D.C., District of Columbia
Related conditions & keywords
Frequently asked questions
What is a clinical trial?
A clinical trial is a research study that tests new medical treatments, drugs, devices, or procedures to determine their safety and effectiveness. Trials are carefully designed and monitored to protect participants while advancing medical knowledge.
Is it safe to participate?
Clinical trials follow strict safety guidelines and ethical standards. Trials must be reviewed and approved, and participants are closely monitored by medical professionals throughout the study. You can withdraw at any time if you choose.
Will I be compensated?
Many clinical trials offer compensation for your time, travel expenses, and inconvenience. The specific compensation varies by study and will be discussed during the screening process. All study-related medical care is typically provided at no cost to participants.
Will I receive a placebo instead of treatment?
When effective treatment exists, participants typically receive either the standard treatment plus the study intervention, or the standard treatment plus placebo. You would not be denied effective care. Placebos are primarily used when no proven treatment is available, or in addition to standard care. Your trial consent form will clearly explain what treatments you may receive.
Can I leave a trial if I change my mind?
Absolutely. Participation in clinical trials is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty or loss of benefits to which you are otherwise entitled.
How long does a clinical trial last?
Trial duration varies widely depending on the study design and purpose. Some trials last just a few weeks, while others may continue for months or years. The study coordinator will provide specific timeline information during your screening call.
Data: ClinicalTrials.gov · synced Feb 13, 2026 · Source of record for eligibility and locations